Knowing that I would have the opportunity to publish Open Access for free in Journal of Experimental Biology made an easy decision of where to submit my manuscript. I am so happy that my article will be more accessible and thus reach a wider audience, because I would not have had the funds for Open Access without this program.
I was delighted to discover that Disease Models & Mechanisms is part of a Read & Publish agreement with the Centro Nacional de Investigaciones Cardiovasculares (CNIC). This arrangement not only streamlined the publishing process but also made it free of charge for authors, ensuring that top-tier research can be published in leading journals without financial barriers. I hope more publishers will follow the forward-thinking example set by The Company of Biologists.
This Read & Publish agreement between The Company of Biologists and the University of California provides an important avenue for disseminating research to everyone interested, without consideration of financial details. The agreement is especially critical for someone like me who, as an Emeritus Professor, no longer maintains significant extramural support yet still performs meaningful work. Thanks so much for helping level the playing field and better democratizing the publication process. Science is for all.
Researchers from IISERs are very keen to publish articles in an Open Access model, without any financial burden. The agreement between the IISER Library Consortium and The Company of Biologists will boost the publications from the participating IISERs.
I was delighted to learn that our paper in Journal of Experimental Biology could be published Open Access without a fee thanks to the Read & Publish agreement between The Company of Biologists and the University of North Carolina at Chapel Hill. This is a wonderful initiative that promotes the work from graduate students and early-career researchers with limited funding, allowing it to reach a wider audience around the world.
Open science is key for our collective knowledge. I find this Read & Publish agreement between The Company of Biologists and Karolinska Institutet very valuable for this endeavour. Thanks to this collaboration, our paper in Journal of Cell Science can reach a wider audience.
I am delighted that USC’s participation in The Company of Biologists’ Open Access agreement enables the broadest, immediate access to our recent publications in Development.
I’m thrilled that the University of California has renewed its transformative Open Access agreement with The Company of Biologists, a mission-driven, community-led publisher that shares UC’s goal of making the scholarly publishing landscape more open. I was a member of the team that negotiated the first Open Access agreement between UC and The Company of Biologists. I have been an author with The Company of Biologists for more than 20 years, and since the start of UC’s partnership with the Company in 2021, UC authors have published more than 85 Open Access articles in its journals, increasing the visibility and impact of their research. I hope that even more UC authors will take advantage of this renewed agreement and make their scholarship freely available to researchers and anyone else around the world by publishing Open Access in The Company of Biologists’ journals.
Read & Publish agreements are an alternative to the traditional subscription model. This agreement will help the researchers/authors from IISERs gradually tip the balance of their publishing output towards Open Access, making the process smoother and research more impactful. The recent collaboration with The Company of Biologists signals a promising surge in scholarly output from IISERs, ushering in a new era of accessible and impactful research. With a Read & Publish agreement in place at IISER Bhopal, article processing charges (APCs) will be waived by the publisher and authors can publish gold Open Access (OA). Authors will also have access to every paper in their journal portfolio.
Publishing Open Access is a vital part of conducting equitable science by making research publications accessible to people who operate outside traditional academic institutions. However, the fees to publish Open Access are a barrier, especially for graduate student researchers. This agreement with The Company of Biologists will greatly contribute to the impact of biology research conducted at UMass.
Visit our journal websites
